Abstract
Purpose
Gross extrathyroidal extension (gETE) into major vessel is considered the most advanced stage of the locally advanced papillary thyroid cancer (PTC). Surgical intervention may not benefit some patients at this disease stage or even result in intraoperative death due to massive hemorrhage; however, it is still considered an effective strategy for most cases. The lack of description for this challenging invasion in PTC warrants detailed characterization of its pattern, risk factors, optimal surgical method, and prognostic value.
Methods
In total, 3127 patients diagnosed as having PTC were enrolled and categorized into two the following groups, namely the major vessel invasion (MVI) group (n = 30) and the control group (n = 3097). Data regarding clinicopathological and demographic characteristics, vascular invasion sites, postoperative complications, locoregional recurrence, distant metastasis, and surgical strategies were collected. Predictive disease-free survival (DFS) was also compared between the two groups.
Results
MVI was independently associated with invasion of the esophageal extension, age < 55 years, tumor size > 1 cm, lateral lymph node metastasis, and distant metastasis (P = 0.00; P = 0.01; 0.05; P = 0.00; P = 0.00, respectively). The difference in the predictive DFS between the two groups was significant (P = 0.00), and the difference remained significant even in patients with ETE when compared with patients without ETE (P = 0.00). Additionally, predictive DFS did not differ significantly between patients who received vessel repairment and those who received vessel resection (P = 0.28).
Conclusions
This study first characterized the gross MVI pattern exhibited by PTC and the risk factors for MVI. Additionally, it demonstrated the DFS of patients with PTC. Extensive gross MVI significantly worsened the biological characteristics of PTC. Regardless of the high risk and difficulty of the operation, patients still benefited from the surgical intervention, and vessel repairment may be the optimal surgical strategy.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
References
Leite AKN, Cavalheiro BG, Kulcsar MA et al (2017) Deaths related to differentiated thyroid cancer: a rare but real event. Arch Endocrinol Metab 61(3):222–227. https://doi.org/10.1590/2359-3997000000261
Nam SH, Roh JL, Gong G et al (2018) Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma. Thyroid 28(1):88–95. https://doi.org/10.1089/thy.2017.0334
Gillanders SL, O’Neill JP (2018) Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC). Eur J Surg Oncol 44(3):286–296. https://doi.org/10.1016/j.ejso.2017.07.013
Zaydfudim V, Feurer ID, Griffin MR, Phay JE (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144(6):1070–1078. https://doi.org/10.1016/j.surg.2008.08.034
Tuttle RM, Haugen B, Perrier ND (2017) Updated American Joint Committee on Cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why? Thyroid 27:751–756
Perrier ND, Brierley JD, Tuttle RM (2018) Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 68(1):55–63. https://doi.org/10.3322/caac.21439
Youngwirth LM, Adam MA, Scheri RP, Roman SA, Sosa JA (2017) Extrathyroidal extension is associated with compromised survival in patients with thyroid cancer. Thyroid 27(5):626–631. https://doi.org/10.1089/thy.2016.0132
Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30(5):780–786. https://doi.org/10.1007/s00268-005-0270-z
Li M, Trivedi N, Dai C et al (2019) Does T stage affect prognosis in patients with stage IV B differentiated thyroid cancer? Endocr Pract 25(9):877–886. https://doi.org/10.4158/EP-2019-0051
McCaffrey JC (2006) Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology. Laryngoscope. https://doi.org/10.1097/01.MLG.0000200428.26975.86
Wada N, Nakayama H, Masudo Y, Suganuma N, Rino Y (2006) Clinical outcome of different modes of resection in papillary thyroid carcinomas with laryngotracheal invasion. Langenbecks Arch Surg. https://doi.org/10.1007/s00423-006-0106-9
Kebebew E, Clark OH (2003) Locally advanced differentiated thyroid cancer. Surg Oncol 12(2):91–99. https://doi.org/10.1016/S0960-7404(03)00032-X
Kobayashi K, Hirokawa M, Yabuta T, Fukushima M, Kihara M, Higashiyama T (2011) Tumour thrombus of thyroid malignancies in veins: importance of detection by ultrasonography. Thyroid 21(5):527–31
Fotis T, Konstantinou E, Mariolis-Sapsakos T et al (2009) Solitary internal jugular vein invasion by thyroid carcinoma: resection and reconstruction. J Vasc Nurs 27(2):46–47. https://doi.org/10.1016/j.jvn.2009.02.001
Patel KN, Shaha AR (2005) Locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg 13(2):112–116. https://doi.org/10.1097/01.moo.0000156161.82671.43
Roh JL (2006) Papillary thyroid carcinoma presenting a great vein invasion in the neck and upper chest. Otolaryngol Head Neck Surg 135(5):818–820. https://doi.org/10.1016/j.otohns.2005.03.035
Peiris B, Koshy K (2020) A commentary on: “STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery” (Int. J. Surg. 72 (2019) 156–165). Int J Surg 83:255–256. https://doi.org/10.1016/j.ijsu.2020.08.039
Kowalski LP, Filho JG (2002) Results of the treatment of locally invasive thyroid carcinoma. Head Neck 24:340–344
Mishra A, Agarwal A, Agarwal G et al (2001) Internal jugular vein invasion by thyroid carcinoma. Eur J Surg 167:64–67
Kawano F, Tomita M, Tanaka H et al (2016) Thyroid carcinoma with extensive tumor thrombus in the superior vena cava: a case report. Int J Surg Case Rep 29:25–29
Mai KT, Khanna P, Yazdi HM et al (2002) Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma. Pathology 34(3):239–244. https://doi.org/10.1080/00313020220131291
Mazzaferri EL (1981) Papillary and follicular thyroid cancer: selective therapy. Compr Ther 7(5):6–14
Furlan JC, Bedard YC, Rosen IB (2004) Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg. https://doi.org/10.1016/j.jamcollsurg.2003.11.012
Wang LY, Nixon IJ, Patel SG et al (2016) Operative management of locally advanced, differentiated thyroid cancer. Surg (United States) 160(3):738–746. https://doi.org/10.1016/j.surg.2016.04.027
Kaufmann C (1879) Die struma maligna primares sarcoma and carcinoma strumae. Dtsch Zeitschrift fur Chir 11:401–402
Xu MS, Li J, Wiseman SM (2019) Major vessel invasion by thyroid cancer: a comprehensive review. Expert Rev Anticancer Ther 19(2):191–203. https://doi.org/10.1080/14737140.2019.1559059
Ingle SA, Karnik ND, Pradhan NN, Ranadive NU, Dhurde A, Kotalwar M (2004) Papillary carcinoma of thyroid presenting as posterior mediastinal mass with superior vena cava syndrome. J Assoc Physicians India 52:1004–1005. http://www.ncbi.nlm.nih.gov/pubmed/15884466
Koike E, Yamashita H, Watanabe S, Yamashita H, Noguchi S (2002) Brachiocephalic vein thrombus of papillary thyroid cancer: report of a case. Surg Today 32(1):59–62. https://doi.org/10.1007/s595-002-8114-7
Sirota DK (1989) Axillary vein thrombosis as the initial symptom in metastatic papillary carcinoma of the thyroid. Mt Sinai J Med 56(2):111–113. http://www.ncbi.nlm.nih.gov/pubmed/2747668
Hyer SL, Dandekar P, Newbold K et al (2008) Thyroid cancer causing obstruction of the great veins in the neck. World J Surg Oncol. https://doi.org/10.1186/1477-7819-6-36
Nishida T, Katayama SI, Tsujimoto M (2002) The clinicopathological significance of histologic vascular invasion in differentiated thyroid carcinoma. Am J Surg 183(1):80–86. https://doi.org/10.1016/S0002-9610(01)00843-1
Falvo L, Catania A, D’Andrea V, Marzullo A, Giustiniani MC, De Antoni E (2005) Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg 241(4):640–646. https://doi.org/10.1097/01.sla.0000157317.60536.08
Huang J, Sun Y, Chen H et al (2019) ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer. Gastric cancer Off J Int Gastric Cancer Assoc Japanese Gastric Cancer Assoc 22(2):287–301. https://doi.org/10.1007/s10120-018-0866-2
Sethi S, Grewal H, Aggarwal P, Narad C (2021) Pattern of tumor invasion, stromal inflammation, angiogenesis and vascular invasion in oral squamous cell carcinoma—a prognostic study. Curr Probl Cancer 45(2):100647. https://doi.org/10.1016/j.currproblcancer.2020.100647
Chen C-Y, Wu S-M, Lin Y-H et al (2019) Induction of nuclear protein-1 by thyroid hormone enhances platelet-derived growth factor A mediated angiogenesis in liver cancer. Theranostics 9(8):2361–2379. https://doi.org/10.7150/thno.29628
Oh HS, Kim SJ, Song E et al (2019) Modified transverse-vertical gross examination: a better method for the detection of definite capsular invasion in encapsulated follicular-patterned thyroid neoplasms. Endocr Pathol 30(2):106–112. https://doi.org/10.1007/s12022-019-9565-8
Skuletic V, Radosavljevic GD, Pantic J et al (2017) Angiogenic and lymphangiogenic profiles in histological variants of papillary thyroid carcinoma. Polish Arch Intern Med 127(6):429–437. https://doi.org/10.20452/pamw.3999
Giaginis C, Alexandrou P, Poulaki E et al (2016) Clinical significance of EphB4 and EphB6 expression in human malignant and benign thyroid lesions. Pathol Oncol Res 22(2):269–275. https://doi.org/10.1007/s12253-014-9879-2
Ferrari SM, Fallahi P, Politti U et al (2015) Molecular targeted therapies of aggressive thyroid cancer. Front Endocrinol (Lausanne) 6:1–10. https://doi.org/10.3389/fendo.2015.00176
Gillotay P, Shankar M, Haerlingen B, Sema Elif E, Pozo-Morales M, Garteizgogeascoa I et al (2020) Single-cell transcriptome analysis reveals thyrocyte diversity in the zebrafish thyroid gland. EMBO Rep 21(12):e50612. https://doi.org/10.15252/embr.202050612
Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood JE et al (2020) The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution. Cell 181(2):236–249. https://doi.org/10.1016/j.cell.2020.03.053
Yan T, Qiu W, Weng H, Fan Y, Zhou G, Yang Z (2021) Single-cell transcriptomic analysis of ecosystems in papillary thyroid carcinoma progression. Front Endocrinol (Lausanne) 12(November):1–9. https://doi.org/10.3389/fendo.2021.729565
Wagner K, Abraham E, Tran B et al (2020) Lymphovascular invasion and risk of recurrence in papillary thyroid carcinoma. ANZ J Surg 90(9):1727–1732. https://doi.org/10.1111/ans.16202
Vuong HG, Kondo T, Duong UNP et al (2017) Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol 177(2):207–216. https://doi.org/10.1530/EJE-17-0260
Wreesmann VB, Nixon IJ, Rivera M et al (2015) Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma. Thyroid 25(5):503–508. https://doi.org/10.1089/thy.2015.0052
Akslen LA, LiVolsi VA (2000) Prognostic significance of histological grading compared with subclassification of papillary thyroid carcinoma. Cancer 88:1902–1908
Sakuragi N, Takeda N, Hareyama H et al (2000) A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer 88:2578–2583
Zeng X, Wang Z, Gui Z et al (2021) High incidence of distant metastasis is associated with histopathological subtype of pediatric papillary thyroid cancer—a retrospective analysis based on SEER. Front Endocrinol (Lausanne) 12(November):1–10. https://doi.org/10.3389/fendo.2021.760901
Vuong HG, Odate T, Duong UNP et al (2018) Prognostic importance of solid variant papillary thyroid carcinoma: a systematic review and meta-analysis. Head Neck 40(7):1588–1597. https://doi.org/10.1002/hed.25123
Feng JW, Ye J, Wu WX et al (2020) Management of clinically solitary papillary thyroid carcinoma patients according to risk-scoring model for contralateral occult carcinoma. Front Endocrinol (Lausanne) 11(October):1–9. https://doi.org/10.3389/fendo.2020.553577
Cao J, Hu JL, Chen C et al (2016) Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study. J Clin Pathol 69(10):872–877. https://doi.org/10.1136/jclinpath-2015-203547
Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24(12):1545–1552. https://doi.org/10.1038/modpathol.2011.119
Arora N, Turbendian HK, Scognamiglio T et al (2008) Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery 144(6):942–948. https://doi.org/10.1016/j.surg.2008.07.023
Shindo ML, Caruana SM, Kandil E et al (2014) Management of invasive well-differentiated thyroid cancer: an American Head And Neck Society consensus statement: AHNS consensus statement. Head Neck 36:1379–1390
Lalak NJ, Campbell PR (1997) Infiltrating papillary carcinoma of the thyroid with macroscopic extension into the internal jugular vein. Otolaryngol Head Neck Surg 117(6):S228–S230. https://doi.org/10.1016/S0194-5998(97)70110-4
Chen W, Lei J, Wang Y et al (2021) Case report: superior vena cava resection and reconstruction for invasive thyroid cancer: report of three cases and literature review. Front Surg 8(June):1–7. https://doi.org/10.3389/fsurg.2021.644605
Al-Jarrah Q, Abou-Foul A, Heis H (2014) Intravascular extension of papillary thyroid carcinoma to the internal jugular vein: a case report. Int J Surg Case Rep 5(8):551–553. https://doi.org/10.1016/j.ijscr.2014.06.005
Acknowledgements
We thank director Jingqiang Zhu of Center of Thyroid and Parathyroid Surgery, West China Hospital for providing administrative support.
Funding
This work was supported by the Science and Technology Department in Sichuan province [2021YFS0103].
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by MA, ZX, BX, CZ, ZW, JZ and AS. The first draft of the manuscript was written by MA and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Ethical approval
Ethical approval was waived by the local Ethics Committee of West China Hospital, Sichuan University, in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
Research involving human participants and/or animals
It was not appropriate or possible to involve patients or the public in the design, or conduct, or reporting, or dissemination plans of our research.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abuduwaili, M., Su, A., Xing, Z. et al. Clinical significance of extrathyroidal extension to major vessels in papillary thyroid carcinoma. J Endocrinol Invest 46, 1155–1167 (2023). https://doi.org/10.1007/s40618-022-01966-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-022-01966-5